Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Por um escritor misterioso

Descrição

Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Best Practices for Managing Postpartum Hypertension
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Preeclampsia up to date—What's going on?
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Sympatholytics: Alpha-2 agonists: Video & Anatomy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Labetalol (AH5158), α1/β-adrenergic Receptors Antagonist
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Blood pressure control in hypertensive disorders of pregnancy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Effectiveness of nifedipine, labetalol, and
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy - Abalos, E - 2018
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Preeclampsia subtypes: Clinical aspects regarding pathogenesis, signs, and management with special attention to diuretic administration - ScienceDirect
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Severe Pre-Eclampsia with Partial Hellp Syndrome in Multigravida Preterm Pregnancy
de por adulto (o preço varia de acordo com o tamanho do grupo)